Modicare - A SWOT Analysis
Healthcare Radius|March 2018

The National Health Protection Scheme brings the Government to the forefront and positions it in the leadership role

Anand Garg
Modicare - A SWOT Analysis

The National Health Protection Scheme (NHPS) aka Modicare announced by the Finance Minister Arun Jaitley in this year’s budget is a good initiative and is a welcome move. Under this plan, christened as ‘Ayushman Bharat’, the central Government will cover 100 million poor families and 500 million people, providing each family an insurance cover of up to Rs 5 lakh per year for secondary and tertiary care or for hospitalisation. The scheme is estimated to cost the Government exchequer about Rs 10, 000 crore annually. 

In India, the secondary and tertiary care penetration is abysmally low with per capita expenditure on healthcare at Rs 13,000 compared with China at Rs 37,000, not to mention the USA at Rs 5, 75, 250 and the UK at Rs 2, 10, 275 respectively; an initiative of this kind is the need of the hour. The central Government’s intent to include poor people from rural, peri- urban and urban areas in the healthcare eco-system is a step in the right direction. In this context, it must be acknowledged that the Government has not only been initiating long-term sustainable systemic reforms across sectors but has also been undertaking initiatives to ensure service delivery to its citizens, particularly in care, education and infrastructure areas.

Successful implementation of any such scheme is the hallmark of availability of adequate financial resources, infrastructure and skilled manpower besides business friendly regulatory environment. So, also is the deployment of technology, particularly in the 21st century where Artificial Intelligence (AI), M2M, Internet of Things (IOT) and Big Data are simplifying things and playing an enabler’s role in developing solutions to find answers to day-to-day problems, thereby making a huge impact in people’s lives and businesses alike.

この記事は Healthcare Radius の March 2018 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Healthcare Radius の March 2018 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

HEALTHCARE RADIUSのその他の記事すべて表示
Dengue-related searches surge on Justdial
Healthcare Radius

Dengue-related searches surge on Justdial

Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.

time-read
1 min  |
September 2024
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Healthcare Radius

Ipca launches NovaLead's Diulcus for diabetic foot ulcer

Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.

time-read
2 分  |
September 2024
Sahyadri Hospitals unveils advanced radiotherapy treatment
Healthcare Radius

Sahyadri Hospitals unveils advanced radiotherapy treatment

Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.

time-read
1 min  |
September 2024
Complex liver transplant saves diabetic patient
Healthcare Radius

Complex liver transplant saves diabetic patient

Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.

time-read
1 min  |
September 2024
Gynecological cancers rise in young Indian women
Healthcare Radius

Gynecological cancers rise in young Indian women

Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.

time-read
1 min  |
September 2024
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Healthcare Radius

Mahajan Imaging, Siemens unveil AI diagnostic analyzer

Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.

time-read
1 min  |
September 2024
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
Healthcare Radius

Nimotuzumab boosts head and neck cancer survival - Tata Memorial study

A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.

time-read
1 min  |
September 2024
Kolkata doctor rape and murder: Everything you wanted to know
Healthcare Radius

Kolkata doctor rape and murder: Everything you wanted to know

Protesting doctors demand better workplace safety and stricter policy measures.

time-read
3 分  |
September 2024
AYUSH treatments to be covered under PM-JAY?
Healthcare Radius

AYUSH treatments to be covered under PM-JAY?

Very soon, AYUSH treatments may be covered under AB PM-JAY.

time-read
2 分  |
September 2024
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Healthcare Radius

WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME

Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.

time-read
2 分  |
September 2024